From regulatory shifts to smarter trial execution, this edition brings practical insights for sponsors navigating early-phase studies across Latin America and Australia. Whether you're streamlining startup processes or refining trial design, you’ll find strategic updates to move you
regulatory · FDA · AI · decentralized · RWD
From regulatory shifts to smarter trial execution, this edition brings practical insights for sponsors navigating early-phase studies across Latin America and Australia. Whether you're streamlining startup processes or refining trial design, you’ll find strategic updates to move your programs forward.
Learn how new FDA guidance is reshaping CGT development. Clarify what real oversight looks like in decentralized trials. Rethink how (and where) to apply RWD in emerging markets. See how AI is quietly transforming early clinical workflows.
Let’s dive into what’s shaping the future of clinical trials. 👇
← All Global Trial Accelerators editions · Contact bioaccess®